Creating new treatments against C. difficile toxins
Developing broad-spectrum therapeutics against C. difficile toxins
This study is working on new treatments and vaccines to help people with C. difficile infections by targeting the harmful toxins it produces, aiming to make them more effective than current options.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-11017773 on NIH RePORTER |
What this research studies
This research focuses on developing innovative therapies to combat the toxins produced by Clostridioides difficile, a harmful bacterium that can disrupt gut health. The team aims to create broad-spectrum antitoxins and new vaccines that target various toxin variants, addressing the limitations of previous treatments that have shown low effectiveness. By studying the structure and function of the toxins and their receptors, the researchers hope to design more effective therapeutic options for patients suffering from C. difficile infections.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have experienced recurrent or severe C. difficile infections.
Not a fit: Patients who are not affected by C. difficile infections or those with other unrelated gastrointestinal conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments and vaccines for patients suffering from C. difficile infections, potentially reducing the severity and recurrence of these infections.
How similar studies have performed: While there have been previous attempts to develop treatments against C. difficile toxins, this approach is novel and aims to address the challenges faced by earlier efforts.
Where this research is happening
Irvine, United States
- University of California-Irvine — Irvine, United States (Active)
Researchers
- Principal investigator: Jin, Rongsheng — University of California-Irvine
- Study coordinator: Jin, Rongsheng
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.